After 18 years, will vTv Therapeutics’ Alzheimer’s drug sink or swim?
vTv Therapeutics has spent nearly two decades advancing its Alzheimer’s drug, and results from two Phase 3 trials are expected in 2018.
vTv Therapeutics has spent nearly two decades advancing its Alzheimer’s drug, and results from two Phase 3 trials are expected in 2018.
A proposed new school of pharmacy and the existing school of health sciences at High Point University have received a $40 million donation from four local families. Each of the families from High Point, North Carolina, donated $10 million to the university. The donation includes a contribution from the family of High Point University President […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.